SEC Form 4 · accession 0002146882-26-000004
BioStem Technologies, Inc. · BSEM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hannaway Rayna Lesser
Director
Period of report
Aug 27, 2026
Accepted (ET)
Aug 28, 2026 · 4:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001658678
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 27, 2026 | M | 7,671 | $0.00 | A | 7,671 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Aug 27, 2026 | M | 7,671 | D | — | — | Common Stock | 7,671 | 0 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- F2These restricted stock units vested on August 27, 2026.
Remarks
Exhibit 24 - Power of Attorney